Vibrio parahaemolyticus strains have been recognized because the causative agent of acute hepatopancreas necrosis illness (Vp AHPND+) in shrimp. Within the current work, a extremely virulent (M0904) and fewer virulent (M0607) pressure of Vp AHPND+ have been utilized in experimental infections of Penaeus vannamei. All through the experiment, histopathological analyses have been carried out on shrimp tissues, and samples from the underside (B) and water column (WC) of every aquarium have been taken to estimate bacterial development. The primary deaths of shrimp challenged with Vp M0904 occurred Four h post-infection (hpi), reached 50% mortality at 17 hpi, and confirmed extra acute pathological development related to AHPND regardless of each strains having related bacterial densities from 0-Four hpi.
The primary deaths of shrimp inoculated with Vp M0607 occurred at 13 hpi, a distinction of 9 h. These shrimps displayed discount of reserve vacuoles in R and B cells of the hepatopancreas, and reached 50% mortality at 27 hpi. As bacterial development within the WC and B within the first hours was related for each strains, bacterial density was not a big think about Vp virulence. Since pirAB toxin is the causative agent of AHPND, it’s doable that there’s a threshold degree at which the toxin damages hepatopancreatic tissues, so manufacturing or secretion of the toxin will be dependent of the Vp pressure. We suggest new AHPND stage: remission with three fundamental routes for the illness final result after the remission stage (re-infection, persistent impact and recuperation). Hepatopancreatic embryonic cells can be utilized as a organic indicator of this stage.
Bacteriological Examine of Digital Gadgets Utilized by Healthcare Staff at Ruhengeri Referral Hospital
Digital units have turn out to be one of the important equipment being utilized in hospitals. These units enhance the communication and get in touch with making healthcare supply extra environment friendly and high quality service oriented. The research was designed to gather dependable details about the spreading of pathogens by digital units particularly in delicate departments. The targets of this research have been to guage the bacterial colonization of digital units and decide the effectiveness of disinfection with alcohol 70% (w/v) to scale back the bacterial colonization of digital units. It was a cross-sectional research the place samples have been collected via moistened swabs in sterile saline resolution from 30 digital units utilized by healthcare staff at Ruhengeri Referral Hospital inside 4 totally different models: maternity, neonathology, intensive care, and theater room. To judge the consequences of disinfection utilizing 70% isopropyl alcohol, the second pattern assortment was carried out after decontamination with 70% isopropyl alcohol. Samples have been analyzed within the microbiology lab of INES-Ruhengeri.
The outcome confirmed that Staphylococcus aureus was essentially the most predominant with 22.5%. Lactobacillus and Citrobacter spp. have been 12.5%; Pseudomonas aeruginosa, coagulase-negative Staphylococci, and Serratia marcescens have been 10%; Escherichia coli was 7.5%; Klebsiella spp. and Providencia spp. have been at 5%. The bottom prevalence was 2.5% of Enterobacter spp. and Salmonella spp. The specter of dissemination of remoted microorganisms is legitimate, since all units evaluated on this research confirmed bacterial contamination of species related to hospital-acquired infections. Particular care needs to be taken when utilizing digital units in healthcare settings along with disinfection to scale back the chance of transmission of bacterial brokers. Additional research ought to consider the antibiotic susceptibility for higher conclusive outcomes since all remoted micro organism on this research have been subjected to excessive resistance and have been related to nosocomial infections.
Bacteriological and histopathological analysis of Penaeus vannamei experimentally infected with Vibrio parahaemolyticus-AHPND strains
A potential research on bacteriological profile and antibiogram of postoperative wound infections in a tertiary care hospital in Western Rajasthan
Background: Surgical web site infections (SSI) are one of the widespread hospital-acquired infections worldwide. SSI are recognized to extend morbidity, mortality, size of keep in hospital in addition to the price of remedy to the sufferers. The incidence varies from 1% to 20% amongst developed international locations to as excessive as 40% in growing world.
Goals: To seek out the incidence and threat components, bacteriological profile, and antibiogram for SSI in Common Surgical procedure division of a tertiary care hospital in Western Rajasthan.
Strategies: Tradition and sensitivity of wounds of all of the clinically suspected instances of SSI have been taken. Bacterial identification and antimicrobial susceptibility have been carried out in keeping with normal CLSI pointers. Statistical evaluation was finished utilizing Microsoft Excel, SPSS 13 software program.
Outcomes: Amongst complete 609 sufferers, 102 have been clinically suspected SSI and 88 have been tradition constructive. Incidence of SSI was 14.45%. The commonest organism was Staphylococcus aureusadopted by Klebsiella pneumoniae. A lot of the Gram-positive isolates have beenproof against penicillin and cephalosporin antibiotics and have been reasonably inclined to fluoroquinolones and aminoglycosides. Gram-negative isolates have been proof against beta-lactam and beta-lactam/beta-lactamase inhibitor mixture additionally however have been inclined to fluoroquinolones, aminoglycosides, and carbapenems.
 BACTERIOLOGICAL AGAR |
|||
| B02-127-2kg | Alphabiosciences | 2kg | EUR 244 |
BACTERIOLOGICAL AGAR |
|||
| B02-127-500g | Alphabiosciences | 500 g | EUR 103 |
 Agar Bacteriological |
|||
| abx082171-500g | Abbexa | 500 g | EUR 578 |
 Peptone Bacteriological |
|||
| abx082173-500g | Abbexa | 500 g | EUR 328 |
) Agar (bacteriological) |
|||
| A2530-2000000 | ApexBio | 2 kg | EUR 383 |
|
Description: microbiological culture mediapasses growth performance tests with known ATCC strainsWilliams, S., Slatko, B., and McCarrey, J., Laboratory Investigations in Molecular BiologyJones and Bartlett, Sudbury, MA (2006)store dry at room temperature, CAS 9002-18-0 |
|||
Agar (bacteriological) |
|||
| A2530-500000 | ApexBio | 500 g | EUR 142 |
|
Description: microbiological culture mediapasses growth performance tests with known ATCC strainsWilliams, S., Slatko, B., and McCarrey, J., Laboratory Investigations in Molecular BiologyJones and Bartlett, Sudbury, MA (2006)store dry at room temperature, CAS 9002-18-0 |
|||
 Peptone, bacteriological |
|||
| A2535-500000 | ApexBio | 500 g | EUR 119 |
|
Description: Enzymatic digest of protein. For use in preparing microbiological culture media. Peptone has been heated a minimum of 80°C for 1 hour, including minimum of 105°C for 30 minutes and dried at a minimum of 140°C. Store in a cool dry place. |
|||
 ELISA Kit) Human Glutathione Reductase (GR) ELISA Kit |
|||
| DLR-GR-Hu-48T | DL Develop | 48T | EUR 498 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Glutathione Reductase (GR) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
|||
Human Glutathione Reductase (GR) ELISA Kit |
|||
| DLR-GR-Hu-96T | DL Develop | 96T | EUR 647 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Glutathione Reductase (GR) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
|||
 ELISA Kit) Rat Glutathione Reductase (GR) ELISA Kit |
|||
| DLR-GR-Ra-48T | DL Develop | 48T | EUR 528 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Glutathione Reductase (GR) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Rat Glutathione Reductase (GR) ELISA Kit |
|||
| DLR-GR-Ra-96T | DL Develop | 96T | EUR 690 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Glutathione Reductase (GR) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Human Glutathione Reductase (GR) ELISA Kit |
|||
| RD-GR-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 500 |
Human Glutathione Reductase (GR) ELISA Kit |
|||
| RD-GR-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 692 |
Rat Glutathione Reductase (GR) ELISA Kit |
|||
| RD-GR-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 534 |
Rat Glutathione Reductase (GR) ELISA Kit |
|||
| RD-GR-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 742 |
Human Glutathione Reductase (GR) ELISA Kit |
|||
| RDR-GR-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 522 |
Human Glutathione Reductase (GR) ELISA Kit |
|||
| RDR-GR-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 724 |
Rat Glutathione Reductase (GR) ELISA Kit |
|||
| RDR-GR-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 558 |
Rat Glutathione Reductase (GR) ELISA Kit |
|||
| RDR-GR-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 776 |
 GR |
|||
| EF016945 | Lifescience Market | 96 Tests | EUR 689 |
GR |
|||
| EF016946 | Lifescience Market | 96 Tests | EUR 689 |
GR |
|||
| EF013656 | Lifescience Market | 96 Tests | EUR 689 |
GR |
|||
| EF012789 | Lifescience Market | 96 Tests | EUR 689 |
GR |
|||
| EF006885 | Lifescience Market | 96 Tests | EUR 689 |
GR |
|||
| EF003969 | Lifescience Market | 96 Tests | EUR 689 |
 HydraAgar? Agar, Bacteriological Grade, 1kg |
|||
| R9002-1kg | ACTGene | EUR 267 | |
 HydraAgar? Agar, Bacteriological Grade, 500g |
|||
| R9002-500g | ACTGene | EUR 170 | |
 GR/ Rat GR ELISA Kit |
|||
| ELA-E1608r | Lifescience Market | 96 Tests | EUR 886 |
 GR Antibody |
|||
| AF5004 | Affbiotech | 200ul | EUR 304 |
|
Description: GR Antibody detects endogenous levels of total GR. |
|||
GR Antibody |
|||
| AF6066 | Affbiotech | 200ul | EUR 304 |
|
Description: GR Antibody detects endogenous levels of total GR. |
|||
GR Antibody |
|||
| AF6067 | Affbiotech | 200ul | EUR 304 |
|
Description: GR Antibody detects endogenous levels of total GR. |
|||
GR Antibody |
|||
| ABF6066 | Lifescience Market | 100 ug | EUR 438 |
GR Antibody |
|||
| ABF6067 | Lifescience Market | 100 ug | EUR 438 |
GR Antibody |
|||
| ABF5004 | Lifescience Market | 100 ug | EUR 438 |
 GR antibody |
|||
| 70R-31028 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal GR antibody |
|||
GR antibody |
|||
| 70R-31293 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal GR antibody |
|||
 GR antibody |
|||
| 23008-100ul | SAB | 100ul | EUR 390 |
 GR 103691 |
|||
| HY-101382 | MedChemExpress | 10mg | EUR 452 |
 GR 46611 |
|||
| B5026-10 | ApexBio | 10 mg | EUR 340 |
GR 46611 |
|||
| B5026-50 | ApexBio | 50 mg | EUR 1276 |
 GR 94800 |
|||
| B5158-1 | ApexBio | 1 mg | EUR 730 |
 GR 64349 |
|||
| B5159-1 | ApexBio | 1 mg | EUR 632 |
 GR 73632 |
|||
| B5160-1 | ApexBio | 1 mg | EUR 583 |
 GR 82334 |
|||
| B5161-1 | ApexBio | 1 mg | EUR 870 |
 GR 135531 |
|||
| B6493-10 | ApexBio | 10 mg | EUR 284 |
GR 135531 |
|||
| B6493-50 | ApexBio | 50 mg | EUR 1038 |
GR 103691 |
|||
| B6600-10 | ApexBio | 10 mg | EUR 248 |
GR 103691 |
|||
| B6600-50 | ApexBio | 50 mg | EUR 886 |
 GR 159897 |
|||
| B6667-10 | ApexBio | 10 mg | EUR 389 |
GR 159897 |
|||
| B6667-50 | ApexBio | 50 mg | EUR 1476 |
 GR 113808 |
|||
| B6688-10 | ApexBio | 10 mg | EUR 340 |
GR 113808 |
|||
| B6688-50 | ApexBio | 50 mg | EUR 1276 |
 GR 231118 |
|||
| B6760-.5 | ApexBio | 500 ug | EUR 627 |
 GR 79236 |
|||
| B6899-10 | ApexBio | 10 mg | EUR 267 |
|
Description: IC50: 3.1 nM (Ki)GR 79236, N-[(1 S, trans)-2-hydroxycyclopentyl] adenosine, is an highly potent and selective adenosine A1 receptor agonist. Adenosine A1 receptor is ubiquitous throughout the entire body, and ofter has an inhibitory function on most of the tissues. |
|||
GR 79236 |
|||
| B6899-5 | ApexBio | 5 mg | EUR 212 |
|
Description: IC50: 3.1 nM (Ki)GR 79236, N-[(1 S, trans)-2-hydroxycyclopentyl] adenosine, is an highly potent and selective adenosine A1 receptor agonist. Adenosine A1 receptor is ubiquitous throughout the entire body, and ofter has an inhibitory function on most of the tissues. |
|||
GR 79236 |
|||
| B6899-5.1 | ApexBio | 10 mM (in 1mL H2O) | EUR 229 |
|
Description: IC50: 3.1 nM (Ki)GR 79236, N-[(1 S, trans)-2-hydroxycyclopentyl] adenosine, is an highly potent and selective adenosine A1 receptor agonist. Adenosine A1 receptor is ubiquitous throughout the entire body, and ofter has an inhibitory function on most of the tissues. |
|||
GR 79236 |
|||
| B6899-50 | ApexBio | 50 mg | EUR 918 |
|
Description: IC50: 3.1 nM (Ki)GR 79236, N-[(1 S, trans)-2-hydroxycyclopentyl] adenosine, is an highly potent and selective adenosine A1 receptor agonist. Adenosine A1 receptor is ubiquitous throughout the entire body, and ofter has an inhibitory function on most of the tissues. |
|||
 HydraAgar? UltraPure Agar, Bacteriological Grade, 1kg |
|||
| R9002UP-1kg | ACTGene | EUR 290 | |
 HydraAgar? UltraPure Agar, Bacteriological Grade, 500g |
|||
| R9002UP-500g | ACTGene | EUR 194 | |
 GR-Beta/ Rat GR- Beta ELISA Kit |
|||
| ELA-E0773r | Lifescience Market | 96 Tests | EUR 886 |
 GR-Alpha/ Rat GR- Alpha ELISA Kit |
|||
| ELA-E0774r | Lifescience Market | 96 Tests | EUR 886 |
) GR antibody (Ser203) |
|||
| 70R-32603 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal GR antibody (Ser203) |
|||
 GR Blocking Peptide |
|||
| AF5004-BP | Affbiotech | 1mg | EUR 195 |
GR Blocking Peptide |
|||
| AF6066-BP | Affbiotech | 1mg | EUR 195 |
GR Blocking Peptide |
|||
| AF6067-BP | Affbiotech | 1mg | EUR 195 |
) GR antibody (Ser211) |
|||
| 70R-31027 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal GR antibody (Ser211) |
|||
) GR antibody (Ser226) |
|||
| 70R-31292 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal GR antibody (Ser226) |
|||
 Antibody) GR (pS211) Antibody |
|||
| 20-abx119224 | Abbexa |
|
|
 GR Polyclonal Antibody |
|||
| ABP54666-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse. This GR antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S203 |
|||
GR Polyclonal Antibody |
|||
| ABP54666-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse. This GR antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S203 |
|||
GR Polyclonal Antibody |
|||
| ABP54666-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse. This GR antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S203 |
|||
GR Polyclonal Antibody |
|||
| ABP54667-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse, Rat. This GR antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S211 |
|||
GR Polyclonal Antibody |
|||
| ABP54667-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse, Rat. This GR antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S211 |
|||
GR Polyclonal Antibody |
|||
| ABP54667-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse, Rat. This GR antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S211 |
|||
GR Polyclonal Antibody |
|||
| ABP54668-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse, Rat. This GR antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S226 |
|||
GR Polyclonal Antibody |
|||
| ABP54668-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse, Rat. This GR antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S226 |
|||
GR Polyclonal Antibody |
|||
| ABP54668-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of GR from Human, Mouse, Rat. This GR antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GR around the non-phosphorylation site of S226 |
|||
 GR repeat Antibody |
|||
| abx233626-100ug | Abbexa | 100 ug | EUR 551 |
 Antibody) GR (pS203) Antibody |
|||
| 20-abx011845 | Abbexa |
|
|
GR (pS203) Antibody |
|||
| 20-abx011847 | Abbexa |
|
|
GR (pS211) Antibody |
|||
| abx011848-100ug | Abbexa | 100 ug | EUR 439 |
 Antibody) GR (pS226) Antibody |
|||
| abx011849-100ug | Abbexa | 100 ug | EUR 439 |
) Glutathione reductase (GR) |
|||
| Y46540005 | Bio Basic | 200U | EUR 113.8 |
Glutathione reductase (GR) |
|||
| Y46541005 | Bio Basic | 1KU | EUR 297.08 |
GR Polyclonal Antibody |
|||
| ES5665-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against GR from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
GR Polyclonal Antibody |
|||
| ES5665-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against GR from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
GR Polyclonal Antibody |
|||
| ES5666-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against GR from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
GR Polyclonal Antibody |
|||
| ES5666-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against GR from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
GR Polyclonal Antibody |
|||
| ES5667-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against GR from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
GR Polyclonal Antibody |
|||
| ES5667-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against GR from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
 Anti-GR antibody |
|||
| STJ98115 | St John's Laboratory | 100 µl | EUR 234 |
|
Description: Mouse monoclonal to GR. |
|||
Anti-GR antibody |
|||
| STJ93409 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to GR. |
|||
Anti-GR antibody |
|||
| STJ93410 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to GR. |
|||
Anti-GR antibody |
|||
| STJ93411 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to GR. |
|||
 GR 55562 dihydrochloride |
|||
| B6572-10 | ApexBio | 10 mg | EUR 334 |
GR 55562 dihydrochloride |
|||
| B6572-50 | ApexBio | 50 mg | EUR 1243 |
 GR 144053 trihydrochloride |
|||
| B6664-10 | ApexBio | 10 mg | EUR 318 |
GR 144053 trihydrochloride |
|||
| B6664-50 | ApexBio | 50 mg | EUR 1178 |
 GR 127935 hydrochloride |
|||
| B6754-10 | ApexBio | 10 mg | EUR 383 |
GR 127935 hydrochloride |
|||
| B6754-50 | ApexBio | 50 mg | EUR 1455 |
 GR 89696 fumarate |
|||
| B6757-10 | ApexBio | 10 mg | EUR 318 |
GR 89696 fumarate |
|||
| B6757-50 | ApexBio | 50 mg | EUR 1178 |
 GR 125487 sulfamate |
|||
| B6818-10 | ApexBio | 10 mg | EUR 373 |
GR 125487 sulfamate |
|||
| B6818-50 | ApexBio | 50 mg | EUR 1357 |
 GR ELISA KIT|Human |
|||
| EF006878 | Lifescience Market | 96 Tests | EUR 689 |
 Antibody) Phospho-GR(Ser203) Antibody |
|||
| AF0042 | Affbiotech | 200ul | EUR 304 |
|
Description: Phospho-GR(Ser203) Antibody detects endogenous levels of GR only when phosphorylated at Sersine 203. |
|||
 Antibody) Phospho-GR (Ser211) Antibody |
|||
| AF2004 | Affbiotech | 200ul | EUR 304 |
|
Description: Phospho-GR (Ser211) Antibody detects endogenous levels of GR only when phosphorylated at Serine 211. |
|||
 Antibody) Phospho-GR (Ser226) Antibody |
|||
| AF3066 | Affbiotech | 200ul | EUR 304 |
|
Description: Phospho-GR (Ser226) Antibody detects endogenous levels of GR only when phosphorylated at Serine 226. |
|||
 Antibody) Phospho-GR (Ser203) Antibody |
|||
| AF3067 | Affbiotech | 200ul | EUR 304 |
|
Description: Phospho-GR (Ser203) Antibody detects endogenous levels of GR only when phosphorylated at Serine 203. |
|||
 Antibody) Phospho- GR (Ser203) Antibody |
|||
| ABF0042 | Lifescience Market | 100 ug | EUR 438 |
 Antibody) Phospho- GR (Ser211) Antibody |
|||
| ABF2004 | Lifescience Market | 100 ug | EUR 438 |
 Antibody) Phospho- GR (Ser226) Antibody |
|||
| ABF3066 | Lifescience Market | 100 ug | EUR 438 |
 Antibody) Phospho- GR (Ser203) Antibody |
|||
| ABF3067 | Lifescience Market | 100 ug | EUR 438 |
) Recombinant Glutathione Reductase (GR) |
|||
| 4-RPB314Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Glutathione Reductase expressed in: E.coli |
|||
Recombinant Glutathione Reductase (GR) |
|||
| 4-RPB314Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Glutathione Reductase expressed in: E.coli |
|||
Recombinant Glutathione Reductase (GR) |
|||
| 4-RPB314Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Glutathione Reductase expressed in: E.coli |
|||
 Anti-GR repeat antibody |
|||
| PAab03626 | Lifescience Market | 100 ug | EUR 412 |
 Antibody) Glutathione Reductase (GR) Antibody |
|||
| 20-abx128017 | Abbexa |
|
|
Glutathione Reductase (GR) Antibody |
|||
| 20-abx129340 | Abbexa |
|
|
Glutathione Reductase (GR) Antibody |
|||
| 20-abx130281 | Abbexa |
|
|
 GR Cell ELISA Kit |
|||
| abx595261-96tests | Abbexa | 96 tests | EUR 637 |
Glutathione Reductase (GR) Antibody |
|||
| 20-abx176657 | Abbexa |
|
|
Glutathione Reductase (GR) Antibody |
|||
| 20-abx172608 | Abbexa |
|
|
Glutathione Reductase (GR) Antibody |
|||
| 20-abx172609 | Abbexa |
|
|
 Antibody) GR (Phospho-Ser226) Antibody |
|||
| 20-abx012430 | Abbexa |
|
|
 Antibody) GR (Phospho-Ser203) Antibody |
|||
| 20-abx012578 | Abbexa |
|
|
Glutathione Reductase (GR) Antibody |
|||
| 20-abx012759 | Abbexa |
|
|
Glutathione Reductase (GR) Antibody |
|||
| 20-abx012772 | Abbexa |
|
|
 Monoclonal GR monoclonal antibody |
|||
| AMM00029G | Leading Biology | 0.05mg | EUR 528 |
|
Description: A Monoclonal antibody against Human GR monoclonal. The antibodies are raised in Mouse. This antibody is applicable in WB, FC, E, IP |
|||
GR (Phospho-Ser226) Antibody |
|||
| 11937-100ul | SAB | 100ul | EUR 252 |
GR (Phospho-Ser226) Antibody |
|||
| 11937-50ul | SAB | 50ul | EUR 187 |
GR (Phospho-Ser203) Antibody |
|||
| 12062-100ul | SAB | 100ul | EUR 252 |
GR (Phospho-Ser203) Antibody |
|||
| 12062-50ul | SAB | 50ul | EUR 187 |
Outcomes: Amongst complete 609 sufferers, 102 have been clinically suspected SSI and 88 have been tradition constructive. Incidence of SSI was 14.45%. The commonest organism was Staphylococcus aureus adopted by Klebsiella pneumoniae. A lot of the Gram-positive isolates have been proof against penicillin and cephalosporin antibiotics and have been reasonably inclined to fluoroquinolones and aminoglycosides. Gram-negative isolates have been proof against beta-lactam and beta-lactam/beta-lactamase inhibitor mixture additionally however have been inclined to fluoroquinolones, aminoglycosides, and carbapenems.